Search Results 51-60 of 166 for ⚠【텔레 GD684】 작대후기% 군미필작업대출 신불자작업대출 신불자작대%⚠

  2. Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    About this study. This is a multicenter Phase 1b, open-label study to assess safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of ...

  3. A Study to Evaluate Larotrectinib to Treat Patients with Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia - Mayo Clinic

    The purpose of this study is to evaluate the side effects and how well larotrectinib works in treating patients with previously untreated TRK fusion solid ...

  4. https://www.mayoclinic.org/~/media/0439A7376021433E8FB3180F95C8FF95

  5. A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma or non-Hodgkin Lymphoma - Mayo Clinic

    The main purpose of this study is to evaluate the safety and tolerability of MT-0169 and establish the MTD (maximum tolerated dose)/ RP2D (recommended phase 2 ...

  7. Publications - Mithun V. Shah, M.D., Ph.D. - Mayo Clinic

    Jabban Y, He R, Bessonen K, Greipp P, Jevremovic D, Foran J, Yi CA, Saliba AN, Hefazi Torghabeh M, Matin A, Hogan W, Mangaonkar A, Patnaik M, Shah M, ...

  8. Patient Stories - Rajiv K. K. Pruthi, M.B.B.S. - Mayo Clinic

    We are transforming healthcare! ... Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each ...

  10. A Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma - Mayo Clinic

    About this study. The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of ...